Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
about
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase.Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?Urinary peptidomics in kidney disease and drug research.
P2860
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@en
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@nl
type
label
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@en
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@nl
prefLabel
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@en
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@nl
P2093
P2860
P50
P356
P1476
Predicting albuminuria respons ...... e 2 diabetes and hypertension.
@en
P2093
Christina Oxlund
Hiddo J L Heerspink
Ib A Jacobsen
Morten Lindhardt
P2860
P304
P356
10.1093/NDT/GFW406
P407
P577
2018-02-01T00:00:00Z